Choroidal neovascularization (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Choroidal neovascularization" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

8doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

1ox.ac.uk

613^th place

456^th place

1aaojournal.org

low place

aaojournal.org (Global: low place; English: low place)

Alster Y, Bressler NM, Bressler SB, Brimacombe JA, Crompton RM, Duh YJ, Gabel VP, Heier JS, Ip MS, Loewenstein A, Packo KH, Stur M, Toaff T (October 2005). "Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study". Ophthalmology. 112 (10): 1758–65. doi:10.1016/j.ophtha.2005.06.008. PMID 16154198.

doi.org (Global: 2^nd place; English: 2^nd place)

Querques G, Srour M, Massamba N, Georges A, Ben Moussa N, Rafaeli O, Souied EH (October 2013). "Functional characterization and multimodal imaging of treatment-naive "quiescent" choroidal neovascularization". Invest Ophthalmol Vis Sci. 54 (10): 6886–92. doi:10.1167/iovs.13-11665. PMID 24084095.
Pfau M, Möller PT, Künzel SH, von der Emde L, Lindner M, Thiele S, Dysli C, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (March 2020). "Type 1 Choroidal Neovascularization Is Associated with Reduced Localized Progression of Atrophy in Age-Related Macular Degeneration". Ophthalmol Retina. 4 (3): 238–248. doi:10.1016/j.oret.2019.09.016. PMID 31753808. S2CID 208226972.
Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen CL, Durbin MK, An L, Stetson PF, Robbins G, Miller A, Zheng F, Rosenfeld PJ (June 2016). "Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration". Ophthalmology. 123 (6): 1309–19. doi:10.1016/j.ophtha.2016.01.044. PMC 5120960. PMID 26876696.
Alster Y, Bressler NM, Bressler SB, Brimacombe JA, Crompton RM, Duh YJ, Gabel VP, Heier JS, Ip MS, Loewenstein A, Packo KH, Stur M, Toaff T (October 2005). "Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study". Ophthalmology. 112 (10): 1758–65. doi:10.1016/j.ophtha.2005.06.008. PMID 16154198.
Reddy U, Kryzstolik M (January 2006). "Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration". The Cochrane Database of Systematic Reviews. 2010 (1) CD005138. doi:10.1002/14651858.CD005138.pub2. PMC 12276864. PMID 16437522.
Takeda AL, Colquitt J, Clegg AJ, Jones J (September 2007). "Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review". The British Journal of Ophthalmology. 91 (9): 1177–82. doi:10.1136/bjo.2007.118562. PMC 1954893. PMID 17475698.
Donati G (2007). "Emerging therapies for neovascular age-related macular degeneration: state of the art". Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde. 221 (6): 366–77. doi:10.1159/000107495. PMID 17947822. S2CID 11256473.
Zhu Y, Zhang T, Xu G, Peng L (December 2016). "Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia". The Cochrane Database of Systematic Reviews. 2016 (12) CD011160. doi:10.1002/14651858.cd011160.pub2. PMC 6464015. PMID 27977064.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Querques G, Srour M, Massamba N, Georges A, Ben Moussa N, Rafaeli O, Souied EH (October 2013). "Functional characterization and multimodal imaging of treatment-naive "quiescent" choroidal neovascularization". Invest Ophthalmol Vis Sci. 54 (10): 6886–92. doi:10.1167/iovs.13-11665. PMID 24084095.
Pfau M, Möller PT, Künzel SH, von der Emde L, Lindner M, Thiele S, Dysli C, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (March 2020). "Type 1 Choroidal Neovascularization Is Associated with Reduced Localized Progression of Atrophy in Age-Related Macular Degeneration". Ophthalmol Retina. 4 (3): 238–248. doi:10.1016/j.oret.2019.09.016. PMID 31753808. S2CID 208226972.
Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen CL, Durbin MK, An L, Stetson PF, Robbins G, Miller A, Zheng F, Rosenfeld PJ (June 2016). "Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration". Ophthalmology. 123 (6): 1309–19. doi:10.1016/j.ophtha.2016.01.044. PMC 5120960. PMID 26876696.
Alster Y, Bressler NM, Bressler SB, Brimacombe JA, Crompton RM, Duh YJ, Gabel VP, Heier JS, Ip MS, Loewenstein A, Packo KH, Stur M, Toaff T (October 2005). "Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study". Ophthalmology. 112 (10): 1758–65. doi:10.1016/j.ophtha.2005.06.008. PMID 16154198.
Reddy U, Kryzstolik M (January 2006). "Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration". The Cochrane Database of Systematic Reviews. 2010 (1) CD005138. doi:10.1002/14651858.CD005138.pub2. PMC 12276864. PMID 16437522.
Takeda AL, Colquitt J, Clegg AJ, Jones J (September 2007). "Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review". The British Journal of Ophthalmology. 91 (9): 1177–82. doi:10.1136/bjo.2007.118562. PMC 1954893. PMID 17475698.
Donati G (2007). "Emerging therapies for neovascular age-related macular degeneration: state of the art". Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde. 221 (6): 366–77. doi:10.1159/000107495. PMID 17947822. S2CID 11256473.
Zhu Y, Zhang T, Xu G, Peng L (December 2016). "Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia". The Cochrane Database of Systematic Reviews. 2016 (12) CD011160. doi:10.1002/14651858.cd011160.pub2. PMC 6464015. PMID 27977064.

ncbi.nlm.nih.gov

"Choroidal neovascularization (Concept Id: C0600518) - MedGen - NCBI". www.ncbi.nlm.nih.gov. Retrieved 13 October 2025.
Roisman L, Zhang Q, Wang RK, Gregori G, Zhang A, Chen CL, Durbin MK, An L, Stetson PF, Robbins G, Miller A, Zheng F, Rosenfeld PJ (June 2016). "Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration". Ophthalmology. 123 (6): 1309–19. doi:10.1016/j.ophtha.2016.01.044. PMC 5120960. PMID 26876696.
Reddy U, Kryzstolik M (January 2006). "Antiangiogenic therapy with interferon alfa for neovascular age-related macular degeneration". The Cochrane Database of Systematic Reviews. 2010 (1) CD005138. doi:10.1002/14651858.CD005138.pub2. PMC 12276864. PMID 16437522.
Takeda AL, Colquitt J, Clegg AJ, Jones J (September 2007). "Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review". The British Journal of Ophthalmology. 91 (9): 1177–82. doi:10.1136/bjo.2007.118562. PMC 1954893. PMID 17475698.
Zhu Y, Zhang T, Xu G, Peng L (December 2016). "Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia". The Cochrane Database of Systematic Reviews. 2016 (12) CD011160. doi:10.1002/14651858.cd011160.pub2. PMC 6464015. PMID 27977064.

ox.ac.uk (Global: 613^th place; English: 456^th place)

ora.ox.ac.uk

Pfau M, Möller PT, Künzel SH, von der Emde L, Lindner M, Thiele S, Dysli C, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (March 2020). "Type 1 Choroidal Neovascularization Is Associated with Reduced Localized Progression of Atrophy in Age-Related Macular Degeneration". Ophthalmol Retina. 4 (3): 238–248. doi:10.1016/j.oret.2019.09.016. PMID 31753808. S2CID 208226972.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Pfau M, Möller PT, Künzel SH, von der Emde L, Lindner M, Thiele S, Dysli C, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (March 2020). "Type 1 Choroidal Neovascularization Is Associated with Reduced Localized Progression of Atrophy in Age-Related Macular Degeneration". Ophthalmol Retina. 4 (3): 238–248. doi:10.1016/j.oret.2019.09.016. PMID 31753808. S2CID 208226972.
Donati G (2007). "Emerging therapies for neovascular age-related macular degeneration: state of the art". Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde. 221 (6): 366–77. doi:10.1159/000107495. PMID 17947822. S2CID 11256473.